Annual SG&A
$22.25 M
+$3.62 M+19.46%
31 December 2021
Summary:
Concert Pharmaceuticals annual selling, general & administrative expenses is currently $22.25 million, with the most recent change of +$3.62 million (+19.46%) on 31 December 2021. During the last 3 years, it has risen by +$3.62 million (+19.46%).CNCE Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.19 M
+$402.00 K+8.40%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly selling, general & administrative expenses is currently $5.19 million, with the most recent change of +$402.00 thousand (+8.40%) on 30 September 2022.CNCE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.59 B
-$126.68 M-8.67%
30 September 2022
Summary:
Concert Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.59 billion, with the most recent change of -$126.68 million (-8.67%) on 30 September 2022.CNCE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +19.5% | -3.8% | -7565.8% |
| 5 y5 years | -2.3% | +11.1% | -7881.1% |
CNCE Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -2.3% | -17.9% | -7073.1% |
Concert Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $5.19 M(+8.4%) | $21.35 M(-1.0%) |
| June 2022 | - | $4.79 M(-12.5%) | $21.55 M(-3.4%) |
| Mar 2022 | - | $5.47 M(-7.5%) | $22.31 M(+0.3%) |
| Dec 2021 | $22.25 M(+19.5%) | $5.91 M(+9.6%) | $22.25 M(+4.6%) |
| Sept 2021 | - | $5.39 M(-2.6%) | $21.27 M(+4.7%) |
| June 2021 | - | $5.54 M(+2.4%) | $20.32 M(+4.5%) |
| Mar 2021 | - | $5.41 M(+9.7%) | $19.44 M(+4.4%) |
| Dec 2020 | $18.62 M(-6.7%) | $4.93 M(+11.1%) | $18.62 M(+0.3%) |
| Sept 2020 | - | $4.44 M(-4.7%) | $18.56 M(-1.2%) |
| June 2020 | - | $4.66 M(+1.3%) | $18.79 M(-1.3%) |
| Mar 2020 | - | $4.60 M(-5.6%) | $19.04 M(-4.7%) |
| Dec 2019 | $19.97 M(-12.3%) | $4.87 M(+4.3%) | $19.97 M(-2.2%) |
| Sept 2019 | - | $4.67 M(-4.8%) | $20.41 M(-7.5%) |
| June 2019 | - | $4.90 M(-11.3%) | $22.06 M(-2.7%) |
| Mar 2019 | - | $5.53 M(+4.1%) | $22.67 M(-0.4%) |
| Dec 2018 | $22.77 M(+8.3%) | $5.31 M(-16.0%) | $22.77 M(+0.6%) |
| Sept 2018 | - | $6.32 M(+14.6%) | $22.65 M(+6.8%) |
| June 2018 | - | $5.51 M(-2.1%) | $21.20 M(-0.9%) |
| Mar 2018 | - | $5.63 M(+8.6%) | $21.40 M(+1.8%) |
| Dec 2017 | $21.02 M | $5.18 M(+6.3%) | $21.02 M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $4.88 M(-14.6%) | $19.35 M(+8.0%) |
| June 2017 | - | $5.71 M(+8.6%) | $17.91 M(+11.7%) |
| Mar 2017 | - | $5.25 M(+49.5%) | $16.03 M(+11.7%) |
| Dec 2016 | $14.36 M(+10.0%) | $3.51 M(+2.1%) | $14.36 M(+1.8%) |
| Sept 2016 | - | $3.44 M(-10.1%) | $14.10 M(+1.2%) |
| June 2016 | - | $3.83 M(+7.0%) | $13.93 M(+3.9%) |
| Mar 2016 | - | $3.58 M(+9.9%) | $13.40 M(+2.6%) |
| Dec 2015 | $13.06 M(+11.6%) | $3.26 M(-0.4%) | $13.06 M(+2.1%) |
| Sept 2015 | - | $3.27 M(-0.9%) | $12.79 M(-1.5%) |
| June 2015 | - | $3.30 M(+2.0%) | $12.98 M(+4.7%) |
| Mar 2015 | - | $3.23 M(+8.2%) | $12.39 M(+5.9%) |
| Dec 2014 | $11.70 M(+45.7%) | $2.99 M(-13.6%) | $11.70 M(+12.8%) |
| Sept 2014 | - | $3.46 M(+27.2%) | $10.38 M(+14.7%) |
| June 2014 | - | $2.72 M(+7.1%) | $9.05 M(+5.2%) |
| Mar 2014 | - | $2.54 M(+52.7%) | $8.60 M(+7.1%) |
| Dec 2013 | $8.03 M(+10.5%) | $1.66 M(-21.9%) | $8.03 M(+0.2%) |
| Sept 2013 | - | $2.13 M(-6.3%) | $8.01 M(+36.2%) |
| June 2013 | - | $2.27 M(+15.7%) | $5.88 M(+63.0%) |
| Mar 2013 | - | $1.96 M(+19.3%) | $3.61 M(+119.3%) |
| Dec 2012 | $7.27 M(-1.5%) | $1.65 M | $1.65 M |
| Dec 2011 | $7.38 M | - | - |
FAQ
- What is Concert Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of CNCE is $22.25 M
What is the all time high annual SG&A for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual selling, general & administrative expenses is $22.77 M
What is Concert Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of CNCE is $5.19 M
What is the all time high quarterly SG&A for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $6.32 M
What is Concert Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of CNCE is -$1.59 B
What is the all time high TTM SG&A for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high TTM selling, general & administrative expenses is $22.77 M